Evidence map›Paper›PMID 40770653›Full record

ArticleBMC research notes2025

Detection of a new bla

Khalifa Jamil Saleh, Muhammad Yusha'u, Abdullahi Hassan Kawo, Evelyn Skiebe, Gottfried Wilharm, Ibrahim Yusuf

Abstract read
In one paragraph

Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Khalifa Jamil SalehDepartment of Microbiology, Faculty of Life Sciences, Bayero University Kano, Kano, Nigeria.
Muhammad Yusha'uDepartment of Microbiology, Faculty of Life Sciences, Bayero University Kano, Kano, Nigeria.
Abdullahi Hassan KawoDepartment of Microbiology, Faculty of Life Sciences, Bayero University Kano, Kano, Nigeria.
Evelyn SkiebeProject Group P2, Robert Koch Institute, Burgstraße 37, 38855, Wernigerode, Germany.
Gottfried WilharmProject Group P2, Robert Koch Institute, Burgstraße 37, 38855, Wernigerode, Germany.
Ibrahim YusufDepartment of Microbiology, Faculty of Life Sciences, Bayero University Kano, Kano, Nigeria. Email-iyusuf.bio@buk.edu.ng.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAcinetobacter baumannii is an opportunistic pathogen with a high capacity to acquire antimicrobial resistance determinants, including OXA-type β-lactamases, which confer resistance to carbapenems. Environmental reservoirs play a crucial role in the persistence and spread of the bacteria; yet, limited data exist on variants of A. baumannii from non-hospital environments; an area critical to epidemiological studies in Nigeria. This study aimed to investigate the genetic diversity of A. baumannii strains from different non-hospital environments in Nigeria, determine their sequence types, and characterize their resistance genes.

resultsIn the course of investigating the prevalence of A. baumannii in 440 environmental samples of soil, sewage, water, and air, collected from three non-hospital communities in Nigeria, isolates with novel features were discovered. Using culture-based and molecular identification, 33 isolates which is equivalent to 7.5% were confirmed as A. baumannii. Whole-genome sequencing of three A. baumannii isolates revealed novel genetic features: isolate S6, obtained from community sewage, harbored a novel bla

Indexed as

Acinetobacter baumanniibeta-LactamasesSewageAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialGenetic VariationHumansMicrobial Sensitivity TestsNigeriaAnti-Bacterial Agentsbeta-lactamase OXA-51, Acinetobacter baumanniibeta-LactamasesSewageAcinetobacter baumanniiBla OXA-51 like genesMolecular diversityNon-hospital environmentSewageVariants

Identifiers

PMID40770653
PMCPMC12329994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.